Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > CEA initiates the first French nanobiotech cluster in Grenoble

CEA initiates the first French nanobiotech cluster in Grenoble

Grenoble, France | September 27, 2005

CEA (French Atomic Energy Commission) the major European Technological Research Organisation, announces the creation of the first French nanobiotechnology cluster. The official launch was made on September 9th with the signature of a real estate operation dedicated to host new equipments and research teams in Grenoble close to the Minatec facilities.

The new cluster, called NanoBio, gathers three research partners: University Joseph Fourier, Hospital of La Tronche and CEA. A first phase is going to be funded by local authorities (Metropolitan Area of Grenoble, Rhone-Alpes Region, Isere Department and City of Grenoble) for a total amount of 23,5 M€. NanoBio will bring together engineers, physicists, chemists, biologists and medical doctors to develop new miniaturised tools for biological and medicine applications: biochips, lab-on-chips, biosensors… These tools will be used for medical diagnosis, food safety control, environmental monitoring, etc.

The aim of NanoBio is to foster the technological and economical development in the bioengineering field, taking advantage of the CEA’s 10-years experience in biochips and bioMEMS research. NanoBio is created in synergy with Minatec, the 1st European innovation Centre for micro and nanotechnology. It will also work in deep connection with Lyon Biopole, a major biotech cluster dedicated to diagnosis and vaccines.

Instigator of both Minatec and NanoBio projects, the CEA is internationally acknowledged for its research in micro and nanotechnologies for life sciences. LETI (Laboratory of Electronics and Information Technologies) has dedicated a full department (120 persons) to micro and nanotechnologies for biology and healthcare, and conducts research projects aimed at technology transfer.

Since 2004, the CEA leads the Nano2Life European network of excellence, gathering 23 partners in 12 countries and more than 200 scientists. Supported by the European Commission, Nano2Life is intended to establish the first steps towards an European Institute of Nanobiotechnology.

####

About CEA Leti:
The CEA plays a major role in research, development and innovation in three main fields: energy, information and healthcare technologies, and defence. Set up on 9 centres located all over France, the CEA benefits from a strong regional insertion and solid partnerships with other research organisations, local authorities and universities.

A laboratory of the CEA in Grenoble, the Laboratory of electronics and information technologies (Leti) is at the leading edge of European research on microelectronics and micro-nanotechnologies. It employs more than 900 people. With its 110 patents filed per year and its twenty-eight start-ups created or in the course of creation, it is one of the major partners of the industrial world.

For more information, please visit www.cea.fr/gb/index.asp

Media Contacts:
Cappe de Baillon
patrick.cappedebaillon@cea.fr

Copyright © CEA Leti

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) October 23rd, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Nanomedicine

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy — Up to 5.0 log10 reduction in HBsAg observed; data presented at HEP DART 2017 — December 6th, 2017

Copper will replace toxic palladium and expensive platinum in the synthesis of medications: The effectiveness of copper nanoparticles as a catalyst has been proven December 5th, 2017

Researchers advance technique to detect ovarian cancer: Rice, MD Anderson use fluorescent carbon nanotube probes to achieve first in vivo success November 30th, 2017

Announcements

UCLA chemists synthesize narrow ribbons of graphene using only light and heat: Tiny structures could be next-generation solution for smaller electronic devices December 8th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Device makes power conversion more efficient: New design could dramatically cut energy waste in electric vehicles, data centers, and the power grid December 8th, 2017

JPK Instruments announce partnership with Swiss company, Cytosurge AG. The partnership makes Cytosurge’s FluidFM® technology available on the JPK NanoWizard® AFM platform December 8th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project